Zenotech Laboratories Limited (ZENOTECH) Share Price
BSE · Healthcare · Drug Manufacturers - Specialty & Generic · ISIN INE486F01012
Key metrics
- Market Cap
- ₹279 Cr
- P/E Ratio
- —
- EPS
- -0.39
- Book Value
- 15.59
- P/B Ratio
- 3.01
- ROE
- -1.13%
- ROCE
- 2.18%
- Debt / Equity
- —
- Net Margin
- -2.71%
- Revenue Growth
- 1.5%
- Profit Growth
- -119.1%
- Dividend Yield
- —
- 52W High
- ₹57.90
- 52W Low
- ₹33.55
- Market Cap Band
- micro cap
- Face Value
- —
Ratios computed from the annual results period ending 2026-03-31.
About Zenotech Laboratories Limited
Zenotech Laboratories Limited manufactures and markets pharmaceutical specialty generic injectables in the oncology and anesthesiology markets in India. It offers contract manufacturing services for parenteral depot formulations, ophthalmic, oncology oral and injectables, and general injectables. The company also leases out its biotech facility and equipment. In addition, it provides granulocyte-colony stimulating factor and granulocyte-macrophage colony-stimulating factor products. Zenotech Laboratories Limited was incorporated in 1989 and is based in Hyderabad, India.
- Headquarters
- Hyderabad, India
- Promoter Holding
- 84.53%
The full Zenotech Laboratories Limited analysis
Create a free account to open the complete ZENOTECH deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.
- 10-year financialsIncome statement, balance sheet and cash flow, year by year.
- Valuation & fair valueFair-value estimates, quality scores and a value grade.
- Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
- Shareholding historyPromoter, FII, DII and public holdings across every quarter.
- Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
- Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.